Northsight Capital Appoints Pharmaceutical And Biotech Sales Industry Veteran John B. Hollister As Chief Executive Officer

Hollister is one of the few executives in the cannabis space who have successfully completed a major funding

SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Northsight Capital, Inc. (OTCBB: NCAP) announced today the appointment of John B. Hollister as CEO. Mr. Hollister brings more than 25 years of commercial management and fundraising experience in related pharmaceutical, biotech and medical device fields including SmithKline Beecham and Amgen. Most recently, as the CEO and Director of NEMUS Bioscience, a biopharmaceutical company developing cannabis-derived pharmaceutical products, Hollister successfully raised over $7M in working capital, including the most recent round of $5M.

As a Director and Global Commercial Leader in Oncology at Amgen, Hollister was responsible for leading several multidisciplinary teams developing oncology molecules, as well as phase IV management of Neulasta. He has a strong working knowledge of all facets of product development and commercialization. Hollister was CEO and Chairman of medical device company EGG Spectrum International, and Senior VP for a diagnostic company, Tethys Bioscience. In addition, Hollister is a long-standing board member for the leading charity in mental health research, the Brain and Behavior Research Foundation. Hollister received his undergraduate degree in Economics from Stanford University and his MBA from the Drucker School of Management at the Claremont Graduate University.

Hollister stated: “With the rapidly evolving view of medical and personal use of marijuana, comes a tremendous need for access to information. Northsight Capital has put together a collection of powerful domains and has built out a virtual community of resources for all things marijuana. We are very excited about helping connect consumers with the information, products, events and services they would like.”

About Northsight Capital

Northsight Capital, Inc. is comprised of a portfolio of online marijuana-related websites that are developed and operated by the company. These sites incorporate many aspects of the marijuana industry. The company intends to provide its audience with a means to stay informed on the industry’s most cutting-edge marijuana-related innovations and legislation. The company’s most dynamic concept, WeedDepot.com, provides consumers with a geo-targeted map directory of medical and recreational dispensaries, head shops, doctors, attorneys and more within the marijuana industry. The Weed Depot app can be downloaded for free at the iTunes Store and Google Play. Weed Depot has an entire platform of content suited for every aspect of advertising and marketing to consumers from all businesses in the cannabis industry. For more information please visit http://www.northsightcapital.com.

Northsight Capital’s current websites include:

• www.Weeddepot.com
• www.420careers.com
• www.MJBizwire.com
• www.MarijuanaRecipes.com
• www.RateMyStrain.com
• www.WikiWeed.com
• www.MarijuanaMd.com
• www.MarijuanaHealthTips.com

Forward-Looking Statements

The statements in this press release constitute forward-looking statements within the meaning of federal securities laws. Such statements are based on our current beliefs and expectations and are inherently subject to significant business, economic and competitive uncertainties and contingencies, many of which are beyond our control. In addition, such forward-looking statements are subject to assumptions with respect to future business strategies and decisions that are subject to change. Potential risks and uncertainties include, but are not limited to, technical advances in the industry as well as political and economic conditions present within the industry. We do not take any obligation to update any forward-looking statement to reflect events or developments after a forward-looking statement was made.